






This is an author version of the contribution published on: 
Questa è la versione dell’autore dell’opera: 
 
EUROPEAN JOURNAL OF WILDLIFE RESEARCH 
Volume: 55, Issue: 6, Pages: 567-573, 2009,  DOI: 10.1007/s10344-009-0270-7 
 
 
The definitive version is available at: 






Anaesthesia of free-ranging Northern chamois (Rupicapra 
rupicapra) with xylazine/ketamine and reversal with atipamezole 
Dematteis A, Menzano A, Canavese G., Meneguz P.G., Rossi L. 
 
A. Dematteis • A. Menzano Ce.Ri.Ge.Fa.S. Centro di Ricerca e Gestione della Fauna Selvatica, fr. Rore, 17-12020, Sampeyre 
(CN), Italy 
G. Canavese Maritime Alps Matural Park, Piazza Regina Elena, 30-12010, Valdieri (CN), Italy 
P. G. Meneguz • L. Rossi Dipartimento di Produzioni Animali, Epidemiologia ed Ecologia, Universita di Torino, V. Leonardo da 
Vinci, 44-10095, Grugliasco (TO), Italy 
 
Abstract One-hundred and fifty-five free-ranging Northern chamois (Rupicapra rupicapra) were 
anaesthetised in the course of a restocking programme using xylazine plus ketamine. Mean±SD 
dosages for xylazine and ketamine were 1.9±0.5 and 2.2±0.7 mg/kg, respectively. In 57 chamois, 
sedation was reversed using 0.3 ±0.1 mg/kg atipamezole. Although all the anaesthetic dosages tested 
immobilised free-ranging Northern chamois, shorter induction times (4.8±2.6 min), deeper sedation 
with no reaction to handling in >90% of the animals and quick reversal (4.0±2.7 min) were obtained 
using 2.5 mg/kg xylazine plus 3.0 mg/kg ketamine reversed with 0.25 mg/ kg atipamezole. Under the 
conditions of this study, suggested standard doses are 63 mg/animal xylazine plus 76 mg/animal 
ketamine reversed by 6.3 mg/animal atipamezole. This anaesthetic protocol improves the results 
from the previous study of Dematteis et al. (Vet Rec 163:184-189, 2008) using xylazine alone. 
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Introduction 
Several anaesthetic protocols have been used to immobilise chamois (Rupicapra spp.): ketamine plus 
medetomidine antagonised with atipamezole (Jalanka and Roeken 1990; Walzer et al. 1996, 1998); 
etorphine plus acepromazine antagonised with diprenorphine (Wiesner et al. 1982); xylazine alone 
(Bauditz 1972; Gauthier 1993a; Peracino and Bassano 1993; Dematteis et al. 2008); xylazine plus 
carfentanyl antagonised with naloxone plus yohimbine (Duchamps 1985); xylazine plus fentanyl 
antagonised with naloxone plus yohimbine (Jensen 1982); xylazine plus ketamine (Wiesner and von 
Hegel 1985; Fico 1988; Moran et al. 1994; von Hardenberg et al. 2000) and tiletamine plus zolazepam 
(Chaduc et al. 1993). However, most of these studies did not evaluate physiological responses to treat-
ment, and the suitability of tested drugs was mainly assessed based on observation, experience and 
anecdotal evidence. 
The aim of this retrospective study was to analyse dosages of xylazine-ketamine combination 
reversed by atipamezole in free-ranging Northern chamois in order to identify a specific and safe 
anaesthetic protocol. The drugs were analysed for their ability to achieve rapid and deep immobilisation 
and effective recovery safely. Furthermore, the possibility of administering a standard dosage irrespec-
tive of sex and body mass is discussed, since environmental operating conditions in the Alps hinder 
prompt adaptation of dosage to the characteristics of the individual target (Dematteis et al. 2008). 
Xylazine is an alfa-2-adrenergic tranquilizer used to immobilise wildlife both as a sole immobilising 
agent (Jorgenson et al. 1990, 1991; Haviernick et al. 1998) and in combination with other anaesthetics 
(Delvaux et al. 1999; Kilpatrick and Spohr 1999; Janovsky et al. 2000). It has a large safety margin since 
its lethal level is more than ten times the normal dosage (Delvaux et al. 1999). Among its potential side 
effects, respiratory depression, rumen stasis and bradycardia may appear at high dosages 
(Jacobsen 1983; Hsu and Shulaw 1984; Jessup et al. 1985; Wallingford et al. 1996). Its half-life is 
approximately 50 min, but effects may last for 1.5-2 h (Plumb 1999). 
Ketamine affects the central nervous system, inducing dissociative anaesthesia (Lin 1996). Desirable 
characteristics include retention of normal reflex actions such as coughing and swallowing. Muscle 
rigidity and violent recoveries occur when ketamine is used alone (Lin 1996); therefore, it is frequently 
used in combination with xylazine (Kilpatrick and Spohr 1999; Telesco and Sovada 2002; Grassman et al. 
2004). Ketamine half-life, reported in cattle and other domestic species, is approximately 60 min 
(Adams 2001). 
Atipamezole is a potent and selective alpha-2-adrenoceptor agonist with a competitive nature (Lin 1996; 
Virtanen 1989) which can antagonise xylazine (Jalanka and Roeken 1990). Currently, there are no 





Materials and methods 
One-hundred and fifty-five Northern chamois (Rupicapra rupicapra; Shackleton and the IUCN/SSC 
Caprinae Specialist Group 1997) were immobilised in the Maritime Alps Natural Park (44° 14' N, 7°23' 
E) in the Southwestern Italian Alps, between 1991 and 2003, for restocking purposes. Two or three 
capture teams operated during the spring (April and May) at 1,000- to 1,300-m elevation. Stone 
shelters were built within 20-50 m of salt licks to facilitate close approach of the chamois. All chamois 
were observed for at least 5 min prior to darting; only animals that appeared to be healthy were 
darted. Following recovery, animals were housed in a dedicated small stable and observed for 4 h to 
3 days before the release. 
Dart guns (11-mm barrel diameter; G.U.T. 50®, Telin-ject, Sturzelbronn, France) fitted with 3-ml syringes 
and 1.5x38-mm plain needles were used to inject the anaesthetic mixture, preferably in the upper thigh 
or in the shoulder blade. Darting distances were determined using a laser distance measurer 
(Rangemaster LRF 800®, Leica, Solms, Germany). 
Free-ranging Northern chamois (7V=191) were immobilised using various dosages of xylazine combined 
with ketamine; however, only chamois darted with a single dose and for which all pertinent anaesthetic, 
physiological and biometric parameters were recorded (see below) have been included in this study 
(7V=155). The effects of xylazine were reversed with atipamezole in 57 of these animals. The 
combination of xylazine-ketamine was obtained dissolving 500 mg xylazine (Rompun® dry 
substance, Bayer, Leverkusen, Germany) in 5 ml of sterile water (solution 100 mg/ml) and then 
mixing 0.2-0.7 ml of this solution to, respectively, 0.8-0.3 ml ketamine (Ketavet® 100, Parke-Davis 
GmbH, Berlin, Germany, 100 mg/ml). For ballistic matters, a standard volume of 1 ml was 
administered to each animal, obtaining the dosages of Table 1. 
Once captured, animals were placed in right lateral recumbency, hobbled, blindfolded and marked 
with plastic ear tags. Body mass, ascertained with spring scales to the nearest 500 g, and body 
measurements were recorded for each animal. Age was estimated by counting horn rings (Schroder 
and von Elsner-Schack 1985), and animals were classified as juveniles (11 to 24 months) or adults. 
Females were tested for pregnancy by abdomen palpation. After processing, atipamezole (5 mg/ml; 
Antisedan®, Orion Corporation Farmos, Turku, Finland) was injected intramuscularly (2.5-13 mg/animal) 
in 57 chamois. Length of spontaneous recovery from anaesthesia was determined in 82 of the 
remaining 98 chamois. 
Physiological parameters were recorded at two intervals from darting in order to monitor for variations 
related to capture: (1) immediately after restraint and (2) 30 min after restraint. Respiratory rate (RR), 
heart rate (HR) and rectal temperature (RT) were measured using, respectively, a clinical 
phonendoscope and a mercury thermometer. Depth and regularity of breathing, colour of the oral and 
ocular mucous membranes, capillary backfill time, rumen activity and muscle tone were monitored at 
various intervals throughout the study. In the event that physiological abnormalities were detected, 
intravenous atipamezole was on hand to reverse sedation. Postmortem examinations were not 
performed. 
For the purposes of this study, "induction" was defined as the interval from sedative injection to 
complete immobilisation (head down); "handling" as the interval between induction and the injection of 
atipamezole; "reversal" as the interval from antagonist administration until the animal was standing and 
"natural recovery" as the time from the anaesthetic injection until the animal was standing (it applied to 
animals which were not injected with atipamezole). 
The depth of sedation was estimated and animals were categorised into three classes based on 
reaction to approach of the operators after induction, standard manipulations (tying limbs and 
blindfolding) and sensitivity to pain (ear tagging). The three classes were: deep sedation (the animal 
did not react when approached, hobbled, blindfolded and tagged); weak sedation (the animal 
did not react when approached, but reacted during containment operations and tagging) and light 
sedation (the animal tried to escape when approached and had to be contained during all 
manipulations). 
Data normality was tested according to the Shapiro-Wilk W test (Altman 1991). Student's t test or 
the Mann-Whitney test or the Wilcox signed rank test were used to assess differences between (1) 
intramuscular vs. thoracic-abdomen xylazine-ketamine administration; (2) drug dosage according to 
age class; (3) induction time according to age class; (4) induction time based on the three classes of 
reaction; (5) physiological measures between intervals 1 and 2 and (6) reversal time according to sex 
and age class. Correlations between xylazine-ketamine dosages and induction time, antidote dosage 
and reversal time, xylazine dosage and reversal time and between atipamezole/xylazine ratio and 
reversal time were evaluated determining Pearson's or Spearman's correlation coefficients. 
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Data are reported as means±SD; statistical significance was set at P<0.05. Statistical analyses were 
performed using R-2.6.0 software (Ihaka and Gentleman 1996). 
 
Results 
One-hundred and fifty-five free-ranging Northern chamois, aged 1-12 years, were immobilised with a 
xylazine-ketamine mixture, including 66 males (5.1 ±3.1 years) and 89 females (5.3±2.5 years). Mean 
body mass was 25.2± 4.2 kg: juvenile males {N=\l) 19.2±3.2 kg (11-23.5 kg), adult males (N=49) 
26.8±3.6 kg (18.6-33 kg), juvenile females {N=9) 19.3±3.5 kg (15-26 kg) and adult females (Af=80) 26±3.2 
kg (20-33 kg). Forty-eight females were pregnant by abdomen palpation (60% of females older than 2 
years); no abortion was recorded during the observation period after recovery or during transport to 
release sites (10-18 h). 
Most chamois (Af=119; 76.8%) were immobilised by intramuscular injection into the rump, hip or 
thigh; the remaining 36 chamois were darted in the thoracic (12.9%) or abdomen areas (10.3%). Since 
no differences were observed in induction time, degree of sedation and mortality, between 
intramuscular and thoracic-abdominal administrations, these data were analysed as a single group. 
The chamois were immobilised with xylazine dosage ranging from 0.8 to 3.6 mg/kg (1.9±0.5 mg/kg) 
plus ketamine dosage ranging from 1.1 to 5.4 mg/kg (2.2± 0.7 mg/kg). Adults (xylazine 1.8±0.47 
mg/kg plus ketamine 2.06±0.53 mg/kg) received significantly lower (P<0.001) doses than juveniles 
(xylazine 2.46±0.58 mg/ kg plus ketamine 2.91 ±0.85 mg/kg). 
Mean induction time was 7.2±5.1 min (range, 1-37 min). Induction time in adults was longer 
than in juveniles (7.5 vs. 5.3; t=2.9, P<0.01). The mean dose of xylazine received by the chamois who 
were immobilised within 10 min (7V=132; 85.2%) was 1.9±0.5 mg/kg, whereas the mean dose of 
ketamine was 2.2±0.7 mg/kg. 
Mean handling time was 71.7±13.4 min. 
Table 2 shows the anaesthetic data for Northern chamois according to the depth of sedation. 
Small but significant differences were detected for RT and RR measured at interval 1 vs. interval 2: 
RT1=39.4± 1.1°C and RT2=39.1±1.2°C (7=1320, P=0.02), RR1 = 88.4±28.8 breaths/min and RR2=84.8±26.9 
breaths/min (F=1242.5, P=0.03). 
Hyperthermia (RT>41°C) was observed in seven chamois (4.5%). Eight animals (5.2%) showed signs 
of sudden respiratory, cardio-circulatory depression (shallow and quick respirations, hypoxic aspect 
of mucous membranes, increased capillary backfill time) during handling. Two of these chamois 
presented respiratory depression after hyperthermia appearance. Minor bloat was observed in other 
five chamois (3.2%), but rumenal punction was not deemed necessary. No sign of muscle stiffness or 
rigidity was recorded. Animals showing one or more of these abnormalities were immediately treated 
with atipamezole. Overall, six animals (3.9%) died (one juvenile and five adults). Four of these 
animals had shown signs of respiratory or cardio-circulatory depression associated in two cases 
with hyperthermia. The other two chamois died during induction time due to injuries suffered after 
a fall from rocks. Chamois with unfavourable outcomes were darted with 2.4±0.7 mg/kg of xylazine 
(1.6-3.3 mg/kg) plus 2.8±1.2 mg/kg of ketamine (1.6-5.0 mg/kg). No unusually stressful pre-darting 
conditions of these animals were recorded. 
In the attempt to define an optimal anaesthetic protocol for the xylazine/ketamine 
combination, we considered   separately  the   chamois   immobilised  with dosages higher than the 
mean values of both drugs, obtaining a subsample of 25 animals immobilised with a mean dosage 
of 2.5 mg/kg xylazine plus 3 mg/kg ketamine. The recorded induction time was 4.8± 2.6 min; 
all animals were immobilised within 10 min and 92% of chamois presented a deep sedation. 
Atipamezole (0.3±0.1 mg/kg) was randomly administered to 57 chamois (36.3%; 25 males and 32 
females) 81.7± 11.0 min after the xylazine-ketamine injection, except for animals that received a 
"therapeutic" treatment because of their abnormal vital signs (Af=18). The mean atipamezole/xylazine 
dose ratio was 1:8.9±3.2. Reversal times varied from 15 s to 19 min (4.0±2.7 min). The remaining 82 
chamois (52.9%) recovered naturally in 139.7±10.2min. 
 
Discussion 
Behavioural and physiological responses to different anaesthetic regimes may vary widely between 
species. Consequently, well-designed experimental protocols can provide valuable objective data 
to inform wildlife operators avoiding unpleasant incidents. In the case of wildlife, however, small 
sample sizes and casual observations are often the only sources of information; this is the case 
with chamois. Jalanka and Roeken (1990) published a review on the use of medetomidine-
ketamine combination in nondomestic mammals, with recommended dosages for captive Northern 
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chamois (N— 49), and provided a range of induction periods (0.7-11.7 min). The same 
combination, but with lower dosages, was used by Walzer et al. (1996, 1998), obtaining an 
effective plan of anaesthesia in 11 free-ranging chamois that showed lateral recumbency on 
average after 6.25 min. Etorphine-acepromazine, fen-tanyl-xylazine, carfentanyl-xylazine and 
tiletamine-zola-zepam combinations were successfully used to immobilise captive chamois (Wiesner 
et al. 1982; Jensen 1982; Duchamps 1985; Chaduc et al. 1993). Detailed information about 
anaesthetic parameters cannot be derived from the original papers. In addition, even at low doses, 
opioids (etorphine, fentanyl and carfentanyl) are potent toxic substances in both animals and 
humans, and extra care and concentration are required by operators when working with these drugs 
(Kreeger et al. 2002). Finally, xylazine alone and combinations of xylazine plus ketamine have been 
frequently used in Northern and in Southern chamois, and some data about anaesthetic times and 
physiological responses were reported (Bauditz 1972; Appolinaire et al. 1984; Wiesner and von Hegel 
1985; Fico 1988; Gauthier 1993a; Peracino and Bassano 1993; Moran et al. 1994; von Hardenberg et al. 
2000; Bassano et al. 2004; Dematteis et al. 2008). 
Induction times have been reported for Southern chamois anaesthetised with xylazine plus 
ketamine, namely 10 and 6.1 min (Appolinaire et al. 1984; Fico 1988). Induction time in this study falls 
in the above range and is similar (7.2±5.1 vs. 7.6±4.4 min) with the average one reported in Northern 
chamois captured in the same study area using xylazine alone (Dematteis et al. 2008). 
In this study, RT and RR slightly decreased between the first and the second interval (during chamois 
handling) with similar ranges as Dematteis et al. (2008), indicating normal physiological reactions of 
chamois to these drugs. Similar RT (39.2±0.5°C) but lower RR (70±19.2 breaths/min) and HR (53±11.3 
beats/min) were reported in Southern chamois (Fico 1988), whereas lower RT (37.7±1.3°C), RR 
(55.6±19.2 breaths/min) and HR (46.7±24.3) were recorded in Northern chamois immobilised with 
xylazine alone (Peracino and Bassano 1993). These differences can be explained by sample size, 
methodological or climatic influences, anaesthetic dosages, timing of measurements, variations in 
instrumentation, ambient temperature or humidity (Jorgenson et al. 1991). Comparing our values with 
the ones recorded in wakeful Northern chamois (Couturier 1938), RT was similar (39.0-39.3°C) and RR 
was lower (25 breaths/min); actually, the elevated RR of our study could reflect a sub-excitement 
state throughout the handling time, as suggested for other chemically captured wild ruminants 
(Walter et al. 2005; Dematteis et al. 2006). 
Hyperthermia appeared with a lower frequency than reported by Dematteis et al. (2008), 4.5% vs. 
7.9%. This is clinically relevant since hyperthermia represents a negative risk factor for 
respiratory/circulatory depression (odds ratio=9.5). The corresponding odds ratio value in Dematteis et 
al. (2008) was 21.1. 
Reported mortality rates for chemically captured free-ranging Caprinae, under a variety of 
scenarios, varied between 0% and 26%, most of which being around 5% (Bergerud et al. 1964; Houston 
1969; Kock et al. 1987; Jolicouer and Beaumont 1986; Gauthier 1993b; Jorgenson et al. 1990; Peracino 
and Bassano 1993; Perez et al. 1997; Kilpatrick and Spohr 1999; Bassano et al. 2004; Dematteis et al. 
2008). In free-ranging Northern chamois captured using medetomidine-ketamine (Walzer et al. 1998) 
and xylazine alone (Peracino and Bassano 1993; Dematteis et al. 2008), mortality rates were 9.1%, 8% 
and 4.6%, respectively. In this study, except for the two traumatic events which occurred during 
induction time, death was always preceded by cardiorespiratory depression. Accurate postmortem 
analyses could not be performed due to the lack of adequate facilities; therefore, definitive causes of 
death remain unknown, but as suggested by Jorgenson et al. (1990), greater though unrecognised 
individual stress before and during immobilisation leading to cardiopulmonary problems was a likely 
explanation. Respiratory/ circulatory depression is a recognised side effect of xylazine (Kreeger et al. 
2002). In our study, it was observed with a lower frequency (5.2%) than following the use of xylazine alone 
(8.8%; Dematteis et al. 2008), suggesting a reduction of drawbacks when xylazine is used in association 
with a dissociative drug like ketamine. This is consistent with reports by other authors (Knight 1980; Lin 
1996; Nielsen 1999; Plumb 1999). 
Abortion is another well-known side effect of xylazine in advanced pregnant ruminants (Richter and 
Gotze 1986; Knight 1980), whereas no risk is reported for ketamine (Fowler and Mikota 2006) and when 
these drugs are combined together (Festa-Bianchet and Jorgenson 1985). In small ruminants, the 
trans-abdominal palpation of the foetus from the fourth month of pregnancy is considered to be an 
accurate diagnostic method with a reliability of 92% (Richter and Gotze 1986). No signs of abortion 
were detected during the observation period. This is consistent with data on Northern chamois 
immobilised with xylazine alone (Peracino and Bassano 1993; Dematteis et al. 2008) and with similar 
experiences on other wild ungulates (Del Giudice et al. 1986; Larsen and Gauthier 1989; Jorgenson et 
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al. 1990; Gauthier 1993b). 
A frequent disadvantage with immobilising drugs is the lack of an antidote and the resulting long 
duration of immobilisation and slow recovery. Currently, alfa-2-adrenergic  tranquilizers  can be  
reversed by  a specific antidote, whereas no effective antagonist exists for ketamine (Kreeger et al. 
2002). Notwithstanding, in this study, the use of atipamezole significantly reduced the length of the 
recovery phase proving to be efficient in neutralising xylazine in chamois; since atipamezole was 
administrated 81.7±11.0 min after anaesthetic injection, it is probable that ketamine action was vanished 
and only xylazine effects needed to be reversed (Plumb 1999; Adams 2001). Atipamezole can be 
particularly useful in emergencies (as happened in this study) or when a rapid release of captured 
wildlife is desirable, but Kreeger et al. (2002) reported that the reversal agent should not be injected 
until at least 30 min after the initial anaesthetic administration, that is, when ketamine serum 
concentration starts to decrease. Atipamezole was administered to a sample of 57 animals at the 
same mean dose of 0.3±0.1 mg/kg previously used by Dematteis et al. (2008) and a similar 
atipamezole/ xylazine mean ratio (1:8.9±3.2 vs. 1:9.4±4.3). Reversal time in this study was lower 
(4.0±2.7 vs. 5.0±2.7 min). In both studies, there was not a significant correlation between 
atipamezole/xylazine ratio and reversal time, suggesting that atipamezole might be effective within 
both ranges and that the recommended atipamezole/xylazine dose ratio of 1:10 (Jalanka and 
Roeken 1990; Arnemo et al. 1993) represents a reference ratio also in this study. Chamois which were 
not injected a reversal agent naturally recovered in 147.2± 11.3 min, similar to 139.7± 10.2 min 
recorded by Dematteis et al. (2008) using xylazine alone and 126.4±26.8 min recorded by Fico (1988) 
using xylazine-ketamine combination in Southern chamois. 
Anaesthetic parameters correlated with the aforementioned optimal xylazine-ketamine dosage 
compare favourably with the ones reported by Dematteis et al. (2008) using their "optimal xylazine 
dosage" (2.6-3.6 mg/kg). In particular, we recorded a lower induction time (4.8±2.6 vs. 6.9±5.2 min), 
a greater number of chamois immobilised within 10 min (100% vs. 86%) and a greater rate of animals in 
the deep sedation class (92% vs. 80.7%). Furthermore, the association of the two drugs permits to 
reduce the xylazine dosage (up to 30.5%) and, in perspective, to decrease the related risk of side 
effects (Plumb 1999). The optimal xylazine-ketamine dosage will also imply a lower atipamezole dosage 
(and therefore a cheaper reversal) than using xylazine alone (Dematteis et al. 2008). 
Based on the reported results, we defined a xylazine-ketamine standard dosage irrespective of sex 
and body mass. Chemical captures of free-ranging chamois are frequently performed by operators 
waiting in emplacement, and it is necessary to prepare an effective dose regardless of age and sex of 
the animal. Moreover, a standard weight of the dart syringe (^standard volume of inoculation) is 
required for ballistic precision. Under field conditions, the optimal dose of drugs can be calculated 
considering the mean weight of the target population during the selected capture period (Dematteis 
et al. 2008). For example, in this study, the mean weight of captured chamois was 25.2 kg and the 
standard dose, based on the optimal combined dosage previously defined (xylazine 2.5 mg/kg plus 
ketamine 3 mg/kg), corresponded to xylazine 63 mg plus ketamine 76 mg. A standard volume of 1.4 
ml per inoculation can be obtained mixing 0.6 ml of a 10% xylazine solution plus 0.8 ml of a 10% 
ketamine solution. To reverse the action of xylazine (in case of alfa-2-adrenergic side effects or to 
obtain a pharmaco-induced recovery starting at least minutes after the administration of the 
anaesthetic solution), it is possible to administer 6.0 mg of atipamezole per animal, corresponding 
to the suggested and generally accepted atipamezole/xylazine ratio of 1:10 (Jalanka and Roeken 
1990; Arnemo et al. 1993). 
In conclusion, we suggest using xylazine associated with ketamine for the immobilisation of free-
ranging Northern chamois, and we recommend atipamezole as a prompt pharmacological agent to 
reverse the alfa-2-adrenergic action. Though the "Hellabrunn mixture" with a xylazine/ ketamine ratio of 
1:0.8 (Wiesner and von Hegel 1985) has been widely used to immobilise the two species of chamois 
(Gauthier 1993a; Wiesner and von Hegel 1985; Fico 1988), we suggest a ratio of 1:1.2 to induce better 
anaesthetic performance. 
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Table 2  Mean anaesthetic dosages administered to Northern chamois according to the depth of sedation 
 
 
 
